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, Plasma Kallikrein, and Trypsin with Amino Acid and Peptide Thioesters: 
Development of Mew Sensitive Substrates, B.J. McRae, K. Kurachi, R.L. Heimark, 
K. Fujikawa, E.W. Davie, and J.C. Powers, Biochemistry 1981, 20 7196-7206. 
Mapping the Substrate Binding Site of Human CIT. and Cli with Peptide Thioesters. 
Development of New Sensitive Substrates. B. J. McRae, T - Y Lin and J.C. Powers, 
J. Biol. Chem. 1981, 256 12362-12366. 
Progress Report  
Scientific Goals. The goal of this research is to understand the nature of 
the active sites of plasma serine proteases and other related trypsin-like enzymes. 
These proteins are the basis of important physiological processes such as blood 
clotting, fibrinolysis and the immune defense mechanism involving the complement 
system. The tools for the investigation will be synthetic peptides. Synthetic 
peptides corresponding to sites which are cleaved by various plasma proteases will 
be prepared. The binding of these peptides to plasma proteases and their rates of 
hydrolysis will be determined. In addition we plan to design and synthesize small 
peptide thioesters which are more reactive toward serine proteases than simple 
peptides. These will be utilized to develop more sensitive and specific assays 
for individual enzymes. 
Progress. During the course of this year we have continued our work with 
amino acid and dipeptide thioesters. In McRae et al., 1981 (reprint enclosed) 
we used thioester to study most of the bovine coagulation factors. In the course 
of this work we developed sensitive substrates for all of the enzymes studied. 
Of special interest was the development of thioester substrates for factor IX a , 
an enzyme for which there was no previous suitable substrate. Several of 
these thioester substrates are now commercially available. In the last year we 
have extended these studies to bovine and human protein C, and to human factor XII a . 
In addition we have used these same thioester substrates to map the active sites 
of two other human trypsin-like enzymes, one from human skin and one from human 
lung. Overall we have now studied over 15 trypsin-like enzymes with the thioester 
substrates. In terms of reactivity the enzymes can be classified into three groups. 
The high reactivity group includes enzymes such as skin trypsin, bovine trypsin 
and kallikrein. The moderate reactivity group includes enzymes such as the lung 
trypsin, factor X and factor XI,. The low reactivity group includes enzymes such 
as factor IX . 	a The thioester a substrates that we have developed are extremely 
sensitive, bet show little specificity. 
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A second avenue of investigation has involved the study of tripeptide 
4-nitroanilide substrates. In our thioester work we discovered that the 
dipeptides which contained either a P I Phe or Gly residue were the most 
reactive. Therefore we decided to syhthesize 4-nitroanilide substrates 
with the following sequences Suc-AA-Gly-Arg-NA and Suc-AA-Phe-Arg-NA. The 
P amino acid residue (AA) was chosen to represent each of the major classes 
of amino acids. Seven substrates in each series were synthesized. The 
amino acids chosen for the P 3  position were Lys, Asn, Ser, Ala, Glu, Pro, and 
Phe. We have now completed 
3
the synthesis of all 14 substrates and are 
measuring kinetic constants with the various enzymes. Thus far we have studied 
thrombin, factor XI,, factor X , trypsin, factor IX , and factor XII . This 
week the studies with bovine protein C have been coApleted, althougha the 
kinetic results are not yet completely corrected. In the next week or two, we 
plan to complete the work with human protein C. In addition to the coagulation 
factors, we have also measured kinetics with the human skin and lung trypsin-
like enzymes. The 131 residue has a substantial effect on the reactivity of 
the various substratds toward the enzymes which we have investigated thus far. 
In fact, it was common to observe two or three orders of magnitute difference 
in 
kcat/KM 
values. The 4-nitroanilide substrates were much less reactive than 
the 	thioester substrates and were also more specific. However none of 
the nitroanilides were completely specific. 
The third avenue of investigation has involved the synthesis of peptides 
containing the activation sequences of bovine factors IX and X and study of 
their reactions with bovine factors XI and IX . The substrates contain a 
fluorophore (Abz) and a quenching gro4 (Nba) which are separated upon enzy-
matic hydrolysis with a resultant increase in fluorescence which was utilized 
to measure hydrolysis rates. Factor XI cleaved all of the peptides bearing 
factor IX activation site sequences. Tee kinetic behavior of factor XI 
toward the synthetic peptide substrates indicates that it has a minimal a 
 extended substrate recognition site at least five residues long and has 
favorable interactions over seven subsites. The hexapeptide Abz-Glu-Phe-Ser- 
Arg-Val-Val-Nba was the most specific factor XI substrate and was not hydrolyzed 
by factors IX , X or thrombin. Phospholipids a had no effect on the reactivity 
of either faclors a IX or X toward synthetic substrates. Both factor IX and X a 
cleaved the peptide substrates at similar rates to their natural substrates 
under comparable conditions. However, the rates were substantially lower than 
optimium activation rates observed in the presence of Ca+ + , phospholipids and 
protein cofactors. In the future it may be useful to investigate synthetic 
substrates which can bind phospholipid vesicles in the same manner as the 





Specific Objectives. The first objective for next year will be to complete 
the kinetic studies with the thioester and 4-nitroanilide substrates that we have 
already synthesized. Studies with human protein C and factor XII remain to be 
done. In addition we expect to obtain some acrosin for study later this summer. 
Another objective will be to investigate the reaction of thioesters with 
zymogens. We have synthesized Z-Gly-SBz1 and Z-Ala-SBz1, and have discovered 
that both are hydrolyzed slowly by chymotrypsinogen. We plan to extend these 
studies to factor X, factor IX, and prothrombin. If these studies are successful, 
we may try to synthesize longer thioesters to make more reactive substrates and 
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increase their specificity. These studies could lead to direct assays for 
coagulation factors without the need of prior proteolytic activation. 
Another goal is to study the P' subsites of thrombin. We plan to 
synthesize Z-Arg-SCHCO-Pro-NH 2 and measure kinetics with thrombin. Due 
to the presence of the 159 ' Pro, this substrate may be specific for thrombin 
and may not react with other coagulation factors. In addition we plan to 
see if there is any difference between the clotting and non-clotting forms 
of thrombin. 
Our final goal will be to begin to synthesize peptides containing the 
structural features of Gla residues. Possible structures would include 
(HO,C),CHCH CH CO-spacer-peptide. Our purpose is to design peptides which 
cou'd bind 2 to 2 phospholipid vesicles in the same manner as the natural 
substrates for factor IX and X . Such substrates might be significantly 
more reactive and specific than a the ones we have prepared to date. One of 
our major overall goals for the future is to increase the specificity of 
various substrates. 
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, Plasma Kallikrein, and Trypsin with Amino Acid and Peptide Thioesters: 
Development of New Sensitive Substrates, B.J. McRae, K. Kurachi, R.L. Heimark, 
K. Fujikawa, E.W. Davie, and J.C. Powers, Biochemistry 1981, 20 7196-7206. 
Mapping the Substrate Binding Site of Human Clr and Cli with Peptide Thioesters. 
Development of Flew Sensitive Substrates. B. J. McRae, T - Y Lin and J.C. Powers, 
J. Biol. Chem. 1981, 256 12362-12366. 
Progress Report  
Scientific Goals. The goal of this research is to understand the nature of 
the active sites of plasma serine proteases and other related trypsin-like enzymes. 
These proteins are the basis of important physiological processes such as blood 
clotting, fibrilolysis and the immune defense mechanism involving the complement 
system. The tools for the investigation will be synthetic peptides. Synthetic 
peptides corresponding to sites which are cleaved by various plasma proteases will 
be prepared. The binding of these peptides to plasma proteases and their rates of 
hydrolysis will be determined. In addition we plan to design and synthesize small 
peptide thioesters which are more reactive toward serine proteases than simple 
peptides. These will be utilized to develop more sensitive and specific assays 
for individual enzymes. 
Progress. During the course of this year we have continued our work with 
amino acid and dipeptide thioesters. In McRae et al., 1981 (reprint enclosed) 
we used thioester to study most of the bovine coagulation factors. In the course 
of this work we developed sensitive substrates for all of the enzymes studied. 
Of special interest was the development of thioester substrates for factor IX a , 
an enzyme for which there was no previous suitable substrate. Several of 
these thioester substrates are now commercially available. In the last year we 
have extended these studies to bovine and human protein C, and to human factor XII a . 
In addition we have used these same thioester substrates to map the active sites 
of two other human trypsin-like enzymes, one from human skin and one from human 
lung. Overall we have now studied over 15 trypsin-like enzymes with the thioester 
substrates. In terms of reactivity the enzymes can be classified into three groups. 
The high reactivity group includes enzymes such as skin trypsin, bovine trypsin 
and kallikrein. The moderate reactivity group includes enzymes such as the lung 
trypsin, factor X and factor XI,. The low reactivity group includes enzymes such 
a as factor IX . 	The thioestera substrates that we have developed are extremely 
sensitive, bat show little specificity. 
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A second avenue of investigation has involved the study of tripeptide 
4-nitroanilide substrates. In our thioester work we discovered that the 
dipeptides which contained either a P„ Phe or Gly residue were the most 
reactive. Therefore we decided to syhthesize 4-nitroanilide substrates 
with the following sequences Suc-AA-Gly-Arg-NA and Suc-AA-Phe-Arg-NA. The 
P amino acid residue (AA) was chosen to represent each of the major classes 
of amino acids. Seven substrates in each series were synthesized. The 
amino acids chosen for the P 3  position were Lys, Asn, Ser, Ala, Glu, Pro, and 
Phe. We have now completed 
3
the synthesis of all 14 substrates and are 
measuring kinetic constants with the various enzymes. Thus far we have studied 
thrombin, factor XI , factor X , trypsin, factor IX , and factor XII . This 
week the studies wieh bovine potein C have been completed, although a the 
kinetic results are not yet completely corrected. In the next week or two, we 
plan to complete the work with human protein C. In addition to the coagulation 
factors, we have also measured kinetics with the human skin and lung trypsin-
like enzymes. The P„ residue has a substantial effect on the reactivity of 
the various substratds toward the enzymes which we have investigated thus far. 





values. The 4-nitroanilide substrates were much less reactive than 
the 	thioester substrates and were also more specific. However none of 
the nitroanilides were completely specific. 
The third avenue of investigation has involved the synthesis of peptides 
containing the activation sequences of bovine factors IX and X and study of 
their reactions with bovine factors XI and IX . The substrates contain a 
fluorophore (Abz) and a quenching grow (Nba) which are separated upon enzy-
matic hydrolysis with a resultant increase in fluorescence which was utilized 
to measure hydrolysis rates. Factor XI cleaved all of the peptides bearing 
factor IX activation site sequences. le kinetic behavior of factor XI 
toward the synthetic peptide substrates indicates that it has a minimal' 
extended substrate recognition site at least five residues long and has 
favorable interactions over seven subsites. The hexapeptide Abz-Glu-Phe-Ser- 
Arg-Val-Val-Nba was the most specific factor XI substrate and was not hydrolyzed 
by factors IX , X or thrombin. Phospholipids a had no effect on the reactivity 
of either faclors a IX or X toward synthetic substrates. Both factor IX and X a 
 cleaved the peptide substrates at similar rates to their natural substrates 
under comparable conditions. However, the rates were substantially lower than 
optimium activation rates observed in the presence of Ca+ + , phospholipids and 
protein cofactors. In the future it may be useful to investigate synthetic 
substrates which can bind phospholipid vesicles in the same mariner as the 





Specific Objectives. The first objective for next year will be to complete 
the kinetic studies with the thioester and 4-nitroanilide substrates that we have 
already synthesized. Studies with human protein C and factor XII remain to be 
done. In addition we expect to obtain some acrosin for study later this summer. 
Another objective will be to investigate the reaction of thioesters with 
zymogens. We have synthesized Z-Gly-SBzl and Z-Ala-SBz1, and have discovered 
that both are hydrolyzed slowly by chymotrypsinogen. We plan to extend these 
studies to factor X, factor IX, and prothrombin. If these studies are successful, 
we may try to synthesize longer thioesters to make more reactive substrates and 
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increase their specificity. These studies could lead to direct assays for 
coagulation factors without the need of prior proteolytic activation. 
Another goal is to study the P' subsites of thrombin. We plan to 
synthesize Z-Arg-SCH 9 CO-Pro-NH 2 and measure kinetics with thrombin. Due 
to the presence of tie P 1 ' Pro, this substrate may be specific for thrombin 
and may not react with other coagulation factors. In addition we plan to 
see if there is any difference between the clotting and non-clotting forms 
of thrombin. 
Our final goal will be to begin to synthesize peptides containing the 
structural features of Gla residues. Possible structures would include 
(HO,C),CHCH CH CO-spacer-peptide. Our purpose is to design peptides which 
coutd bind 2 to
2 
phospholipid vesicles in the same manner as the natural 
substrates for factor IX and X . Such substrates might be significantly 
more reactive and specific than a the ones we have prepared to date. One of 
our major overall goals for the future is to increase the specificity of 
various substrates. 
